"HIV Seropositivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).
| Descriptor ID |
D006679
|
| MeSH Number(s) |
C02.782.815.616.400.500 C02.800.801.400.500 C20.673.480.500
|
| Concept/Terms |
HIV Seropositivity- HIV Seropositivity
- HIV Seropositivities
- Seropositivities, HIV
- Seropositivity, HIV
- AIDS Seropositivity
- AIDS Seropositivities
- Seropositivities, AIDS
- Seropositivity, AIDS
- Anti-HIV Positivity
- Anti HIV Positivity
- Anti-HIV Positivities
- Positivities, Anti-HIV
- Positivity, Anti-HIV
- HTLV-III Seropositivity
- HTLV III Seropositivity
- HTLV-III Seropositivities
- Seropositivities, HTLV-III
- Seropositivity, HTLV-III
- HIV Seroconversion
- HIV Seroconversions
- Seroconversion, HIV
- Seroconversions, HIV
- HTLV-III Seroconversion
- HTLV III Seroconversion
- HTLV-III Seroconversions
- Seroconversion, HTLV-III
- Seroconversions, HTLV-III
- AIDS Seroconversion
- AIDS Seroconversions
- Seroconversion, AIDS
- Seroconversions, AIDS
- HIV Antibody Positivity
- Antibody Positivities, HIV
- Antibody Positivity, HIV
- HIV Antibody Positivities
- Positivities, HIV Antibody
- Positivity, HIV Antibody
|
Below are MeSH descriptors whose meaning is more general than "HIV Seropositivity".
Below are MeSH descriptors whose meaning is more specific than "HIV Seropositivity".
This graph shows the total number of publications written about "HIV Seropositivity" by people in this website by year, and whether "HIV Seropositivity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 1 | 4 |
| 1995 | 3 | 3 | 6 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 2 | 3 |
| 1998 | 4 | 2 | 6 |
| 1999 | 2 | 1 | 3 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 3 | 4 |
| 2003 | 4 | 1 | 5 |
| 2004 | 1 | 2 | 3 |
| 2006 | 3 | 1 | 4 |
| 2007 | 1 | 2 | 3 |
| 2009 | 4 | 0 | 4 |
| 2010 | 2 | 0 | 2 |
| 2011 | 7 | 2 | 9 |
| 2012 | 10 | 1 | 11 |
| 2013 | 3 | 1 | 4 |
| 2014 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 3 | 4 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 1 | 3 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV Seropositivity" by people in Profiles.
-
Texas Developmental Center for AIDS Research CFAR Diversity, Equity, and Inclusion Pathway Initiative Program. J Acquir Immune Defic Syndr. 2023 10 01; 94(2S):S80-S85.
-
Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms. Front Immunol. 2023; 14:1167965.
-
HIV-1 Vpu protein forms stable oligomers in aqueous solution via its transmembrane domain self-association. Sci Rep. 2023 09 06; 13(1):14691.
-
Intravenous tecovirimat treatment of oral monkeypox lesions in a patient with HIV-1. J Med Virol. 2023 09; 95(9):e29078.
-
Herpesvirus Infection Masquerading as a Neoplasm in an HIV-Positive Patient: A Potential Diagnostic Pitfall. Am J Dermatopathol. 2023 May 01; 45(5):333-336.
-
The barriers and facilitators of HIV-exposed infant testing as perceived by HIV-positive mothers in Botswana: A qualitative study. PLoS One. 2022; 17(8):e0273777.
-
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial. Nat Med. 2022 06; 28(6):1288-1296.
-
Daily Associations Between Alcohol Consumption and Antiretroviral Therapy (ART) Adherence Among HIV-Positive Men Who Have Sex With Men. AIDS Behav. 2022 Oct; 26(10):3153-3163.
-
Paediatric tuberculosis - new advances to close persistent gaps. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S63-S67.
-
Predicting Sexually Transmitted Infections Among HIV+ Adolescents and Young Adults: A Novel Risk Score to Augment Syndromic Management in Eswatini. J Acquir Immune Defic Syndr. 2020 12 15; 85(5):543-552.